Abstract Pre-adolescent girls (9–15 years) have the option of receiving a two dose HPV
vaccine series at either a six month or one year interval to provide protection from HPV 16 …

In 2014, the Food and Drug Administration approved a new human papillomavirus 9-valent
vaccine (9vHPV), targeting nine HPV types: HPV types 6, 11, 16, and 18, which are also …

Recommendations of the Advisory Committee on Immunization Practices for use of herpes
zoster vaccines - ScienceDirect Skip to main contentSkip to article Elsevier logo Journals & …

Methods Prevalence and incidence were estimated for infections with any HPV (any of 37
types detected using Linear Array) and disease-associated HPV, 2 types that cause …

Purpose: Gaps remain in the public's knowledge of the human papillomavirus (HPV). We
assessed racial/ethnic and gender disparities in knowledge and awareness of HPV and the …

Background: In the United States, the routine age for human papillomavirus (HPV)
vaccination is 11 to 12 years, with catch-up vaccination through age 26 years for women and …

Studies with prophylactic HPV vaccination have demonstrated impressive efficacy,
immunogenicity, and safety results; however, the implementation and uptake in both low and …

Clinical reports from the American Academy of Pediatrics benefit from expertise and
resources of liaisons and internal (AAP) and external reviewers. However, clinical reports …

Background The success of human papillomavirus (HPV) national immunization program
depends on effective strategies in optimizing the uptake of HPV vaccine. Given the …

Estimates of medical care costs for cervical and other cancers associated with human
papillomavirus (HPV) are higher in studies published in recent years than in studies …